MARKET

ETON

ETON

Eton Pharmaceuticals
NASDAQ
14.22
-0.56
-3.79%
After Hours: 14.00 -0.22 -1.55% 18:31 03/21 EDT
OPEN
14.52
PREV CLOSE
14.78
HIGH
14.63
LOW
14.15
VOLUME
224.15K
TURNOVER
--
52 WEEK HIGH
18.41
52 WEEK LOW
3.030
MARKET CAP
381.35M
P/E (TTM)
-96.3415
1D
5D
1M
3M
1Y
5Y
1D
Eton Pharmaceuticals Is Maintained at Buy by Craig-Hallum
Dow Jones · 4d ago
Craig-Hallum Maintains Buy on Eton Pharmaceuticals, Raises Price Target to $26
Benzinga · 4d ago
Eton Pharmaceuticals Price Target Raised to $24.00/Share From $21.00 by B. Riley Securities
Dow Jones · 4d ago
B. Riley Securities Reiterates Buy on Eton Pharmaceuticals, Raises Price Target to $24
Benzinga · 4d ago
5 Analysts Assess Eton Pharmaceuticals: What You Need To Know
Benzinga · 4d ago
Eton Pharmaceuticals Price Target Maintained With a $33.00/Share by HC Wainwright & Co.
Dow Jones · 4d ago
HC Wainwright & Co. Reiterates Buy on Eton Pharmaceuticals, Maintains $33 Price Target
Benzinga · 4d ago
BUZZ-U.S. STOCKS ON THE MOVE-Aditxt, Natgas companies, DocuSign
Reuters · 5d ago
More
About ETON
Eton Pharmaceuticals, Inc. is a pharmaceutical company focused on developing and commercializing treatments for rare diseases. The Company has six commercial rare disease products: INCRELEX, ALKINDI SPRINKLE, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous, and Nitisinone. INCRELEX is a biologic product used to treat pediatric patients 2 years of age and older who suffer from severe primary insulin-like growth factor 1 deficiency (SPIGFD). ALKINDI SPRINKLE is for the treatment of pediatric adrenocortical insufficiency. Carglumic Acid is for the treatment of hyperammonemia due to N-acetylglutamate synthase (NAGS) deficiency. Betaine Anhydrous is for the treatment of homocystinuria. Nitisinone is for the treatment of hereditary tyrosinemia type 1 (HT-1). PKU GOLIKE is a medical formula for patients with phenylketonuria (PKU). Galzin, its product, is FDA-approved for the treatment of the ultra-rare metabolic condition of Wilson Disease.

Webull offers Eton Pharmaceuticals Inc stock information, including NASDAQ: ETON real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ETON stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ETON stock methods without spending real money on the virtual paper trading platform.